APASL2024-话题@MedSci

#APASL2024#

0篇内容 | 158人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2198416, encodeId=238b21984161c, content=<a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=f7e311261088' target=_blank style='color:#2F92EE;'>#APASL2024#</a> <a href='/topic/show?id=d13311336558' target=_blank style='color:#2F92EE;'>#ALT阈值#</a>, objectTitle=【APASL2024速递】降低ALT阈值可提高慢乙肝患者的总体应治率至90%以上, objectType=article, longId=820164, objectId=483b820164c0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/diagnostic-form-in-hospital-conceptual-image-7JAH3GT.jpg, objectUrl=/article/show_article.do?id=483b820164c0, replyNumber=0, likeNumber=14, createdTime=2024-04-14, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=483b820164c0, moduleTitle=【APASL2024速递】降低ALT阈值可提高慢乙肝患者的总体应治率至90%以上, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=483b820164c0)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2198419, encodeId=5da321984197a, content=<a href='/topic/show?id=cb65813029a' target=_blank style='color:#2F92EE;'>#肝硬化#</a> <a href='/topic/show?id=3ed881343fa' target=_blank style='color:#2F92EE;'>#肝纤维化#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=f7e311261088' target=_blank style='color:#2F92EE;'>#APASL2024#</a> <a href='/topic/show?id=5ed111336960' target=_blank style='color:#2F92EE;'>#血清N-聚糖#</a>, objectTitle=【APASL2024速递】新型标志物：血清N-聚糖模型可用于区分ALT正常慢乙肝患者的显著肝纤维化和肝硬化, objectType=article, longId=820310, objectId=f8fe820310ff, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/health-insurance-PK235DP.jpg, objectUrl=/article/show_article.do?id=f8fe820310ff, replyNumber=0, likeNumber=20, createdTime=2024-04-14, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=f8fe820310ff, moduleTitle=【APASL2024速递】新型标志物：血清N-聚糖模型可用于区分ALT正常慢乙肝患者的显著肝纤维化和肝硬化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8fe820310ff)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2198071, encodeId=126521980e16d, content=<a href='/topic/show?id=370d8126914' target=_blank style='color:#2F92EE;'>#肝癌#</a> <a href='/topic/show?id=f7e311261088' target=_blank style='color:#2F92EE;'>#APASL2024#</a>, objectTitle=【APASL2024速递】中山市肝癌筛查项目成果：定期肝癌筛查可有效提高肝癌患者的生存率, objectType=article, longId=819800, objectId=7ad6819800a1, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/health-insurance-PK235DP.jpg, objectUrl=/article/show_article.do?id=7ad6819800a1, replyNumber=0, likeNumber=15, createdTime=2024-04-11, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=7ad6819800a1, moduleTitle=【APASL2024速递】中山市肝癌筛查项目成果：定期肝癌筛查可有效提高肝癌患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ad6819800a1)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2197859, encodeId=b11d219e859de, content=<a href='/topic/show?id=769099e24d7' target=_blank style='color:#2F92EE;'>#非酒精性脂肪性肝病#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=018880e834b' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α-2b#</a> <a href='/topic/show?id=f7e311261088' target=_blank style='color:#2F92EE;'>#APASL2024#</a>, objectTitle=【APASL2024速递】聚乙二醇干扰素α-2b可显著改善合并NAFLD的慢乙肝患者代谢紊乱, objectType=article, longId=819683, objectId=41ee81968321, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/prescription-form-with-medical-stethoscope-9ZRKVHM.jpg, objectUrl=/article/show_article.do?id=41ee81968321, replyNumber=0, likeNumber=15, createdTime=2024-04-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=41ee81968321, moduleTitle=【APASL2024速递】聚乙二醇干扰素α-2b可显著改善合并NAFLD的慢乙肝患者代谢紊乱, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41ee81968321)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2197752, encodeId=1000219e75253, content=<a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=f7e311261088' target=_blank style='color:#2F92EE;'>#APASL2024#</a> <a href='/topic/show?id=d8f311323032' target=_blank style='color:#2F92EE;'>#间歇治疗#</a>, objectTitle=【APASL2024速递】间歇治疗或联合治疗提高慢乙肝疗效的机制探索, objectType=article, longId=819569, objectId=1b648195692c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/hospital-staff-at-work-PGMH47J.jpg, objectUrl=/article/show_article.do?id=1b648195692c, replyNumber=0, likeNumber=14, createdTime=2024-04-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=1b648195692c, moduleTitle=【APASL2024速递】间歇治疗或联合治疗提高慢乙肝疗效的机制探索, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b648195692c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2197472, encodeId=08da219e472b1, content=<a href='/topic/show?id=370d8126914' target=_blank style='color:#2F92EE;'>#肝癌#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=412f62143da' target=_blank style='color:#2F92EE;'>#核苷#</a> <a href='/topic/show?id=f7e311261088' target=_blank style='color:#2F92EE;'>#APASL2024#</a>, objectTitle=【APASL2024速递】长期核苷治疗的慢乙肝患者的肝癌风险预测, objectType=article, longId=819420, objectId=adb2819420ab, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-doctor-hand-with-pen-BWV9L2K.jpg, objectUrl=/article/show_article.do?id=adb2819420ab, replyNumber=0, likeNumber=21, createdTime=2024-04-08, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=adb2819420ab, moduleTitle=【APASL2024速递】长期核苷治疗的慢乙肝患者的肝癌风险预测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=adb2819420ab)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2195829, encodeId=4003219582940, content=<a href='/topic/show?id=f7e311261088' target=_blank style='color:#2F92EE;'>#APASL2024#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=142911284051' target=_blank style='color:#2F92EE;'>#HBV突变#</a>, objectTitle=【APASL2024速递】HBV突变对慢乙肝患者远期结局的影响, objectType=article, longId=817938, objectId=941381e938c9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-team-discussing-together-in-the-hallway-PJWSSDB.jpg, objectUrl=/article/show_article.do?id=941381e938c9, replyNumber=0, likeNumber=0, createdTime=2024-03-28, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=941381e938c9, moduleTitle=【APASL2024速递】HBV突变对慢乙肝患者远期结局的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=941381e938c9)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2194904, encodeId=8d6821949044d, content=<a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=f7e311261088' target=_blank style='color:#2F92EE;'>#APASL2024#</a>, objectTitle=【APASL2024速递】不确定期研究汇总：不确定期慢乙肝患者易发生分期转变，疾病进展风险高, objectType=article, longId=817790, objectId=cffe81e79062, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/close-up-of-doctors-with-clipboard-at-hospital-PXE5DKE.jpg, objectUrl=/article/show_article.do?id=cffe81e79062, replyNumber=0, likeNumber=16, createdTime=2024-03-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=cffe81e79062, moduleTitle=【APASL2024速递】不确定期研究汇总：不确定期慢乙肝患者易发生分期转变，疾病进展风险高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cffe81e79062)], followStatus=false, userIsMember=false, type=null, lengthMark=0)] 梅斯管理员

慢乙肝 APASL2024

2024-03-23发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#慢乙肝# #APASL2024# #ALT阈值#

【APASL2024速递】降低ALT阈值可提高慢乙肝患者的总体应治率至90%以上

2024-04-14发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#肝硬化# #肝纤维化# #慢乙肝# #APASL2024# #血清N-聚糖#

【APASL2024速递】新型标志物：血清N-聚糖模型可用于区分ALT正常慢乙肝患者的显著肝纤维化和肝硬化

2024-04-14发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#肝癌# #APASL2024#

【APASL2024速递】中山市肝癌筛查项目成果：定期肝癌筛查可有效提高肝癌患者的生存率

2024-04-11发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#非酒精性脂肪性肝病# #慢乙肝# #聚乙二醇干扰素α-2b# #APASL2024#

【APASL2024速递】聚乙二醇干扰素α-2b可显著改善合并NAFLD的慢乙肝患者代谢紊乱

2024-04-10发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#慢乙肝# #APASL2024# #间歇治疗#

【APASL2024速递】间歇治疗或联合治疗提高慢乙肝疗效的机制探索

2024-04-10发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#肝癌# #慢乙肝# #核苷# #APASL2024#

【APASL2024速递】长期核苷治疗的慢乙肝患者的肝癌风险预测

2024-04-08发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#APASL2024# #慢乙肝# #HBV突变#

【APASL2024速递】HBV突变对慢乙肝患者远期结局的影响

2024-03-28发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#慢乙肝# #APASL2024#

【APASL2024速递】不确定期研究汇总：不确定期慢乙肝患者易发生分期转变，疾病进展风险高

2024-03-23发表于上海

科室
- - 订阅+
  - 更多科室
工具
服务